Skip to main content

Table 4 Multivariate analysis relationship between factors and survival

From: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Variable Hazard Ratio (95%) CI p value
Lymph Node Involvement (yes) 0.946 (0.508–1.761) 0.861
Tumor Stage (III-IV) 2.585 (1.345–4.968) 0.004
Transgelin-2 p-S145 (high) 1.918 (1.185–3.102) 0.008